What is Dermata Therapeutics, Inc. Common Stock's Market Cap?

Dermata Therapeutics, Inc. Common Stock's Market Cap is $5.0M, based on as-reported figures from SEC (XBRL) filings.

What is Dermata Therapeutics, Inc. Common Stock's Net Income (TTM)?

Dermata Therapeutics, Inc. Common Stock's Net Income (TTM) is -$8.4M, based on as-reported figures from SEC (XBRL) filings.

What is Dermata Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Dermata Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.08, based on as-reported figures from SEC (XBRL) filings.

Dermata Therapeutics, Inc. Common Stock (DRMA) Financial Statements

Dermata Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG011DJT0Y1

XNAS · usd

1.25▲ 0.04 (3.31%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close1.21

Day's Range1.21 – 1.31

52-Week Range0.95 – 6.22

Volume50.5K

Avg Volume688.7K

Share Statistics

Shares Outstanding

Employees9

ExchangeXNAS

Listed2021-08-13

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Dermata Therapeutics, Inc. Common Stock (DRMA)

What is Dermata Therapeutics, Inc. Common Stock's Market Cap?: Dermata Therapeutics, Inc. Common Stock's Market Cap is $5.0M, based on as-reported figures from SEC (XBRL) filings.
What is Dermata Therapeutics, Inc. Common Stock's Net Income (TTM)?: Dermata Therapeutics, Inc. Common Stock's Net Income (TTM) is -$8.4M, based on as-reported figures from SEC (XBRL) filings.
What is Dermata Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Dermata Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.08, based on as-reported figures from SEC (XBRL) filings.